More Tantalizing Clues Oxytocin May Be an Effective Autism Treatment

In a preliminary presentation of new research, doctors said a nasal spray containing the hormone helped activate "social" regions of the brain.

The Doctor Will See You Now
Synchronista/Shutterstock

Oxytocin, the "mother-infant bonding hormone," holds even more promise for helping treat the social deficits that are often part of autism spectrum disorder (ASD). Where earlier work piqued interest in oxytocin as a possible treatment, a new study goes further to support its role in treating the disorder, which now affects one in 88 children born today, according to the CDC.

The brains of the children who had received the oxytocin showed that areas of the "social brain," were activated.

In the new study, the authors conducted a double-blind placebo-controlled trial, the gold standard of scientific research. The team gave half of a group of children aged 7-18 a single dose of a nasal spray containing oxytocin. The other half of the group received a placebo - a nasal spray with no active ingredient in it.

The brains of the children who had received the oxytocin showed that areas of the "social brain," were activated. These included the medial prefrontal cortex, the temporal parietal junction, the fusiform gyrus and the superior temporal sulcus, all areas involved in processing social information coming from sight, sounds, and cues from other people.

Oxytocin is secreted in large amounts during and after childbirth, and is thought to help a mother and her baby bond. It also appears to support other, non-maternal social behaviors, like feeling more open and trusting towards other people.

"Our findings provide the first, critical steps toward devising more effective treatments for the core social deficits in autism, which may involve a combination of clinical interventions with an administration of oxytocin," said study author Ilanit Gordon. "Such a treatment approach will fundamentally improve our understanding of autism and its treatment." The findings are preliminary, however, and the treatment will need more rigorous investigation before it could be recommended for use in the general public.

The study was carried out at Yale University, and the findings presented at the International Meeting for Autism Research in May. They are not yet scheduled to appear in a peer-reviewed journal.


This article originally appeared on TheDoctorWillSeeYouNow.com, an Atlantic partner site.

Presented by

Alice G. Walton, PhD, is a health journalist and an editor at The Doctor Will See You Now.

Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register with Disqus.

Please note that The Atlantic's account system is separate from our commenting system. To log in or register with The Atlantic, use the Sign In button at the top of every page.

blog comments powered by Disqus

Video

A Stop-Motion Tour of New York City

A filmmaker animated hundreds of still photographs to create this Big Apple flip book

Video

The Absurd Psychology of Restaurant Menus

Would people eat healthier if celery was called "cool celery?"

Video

This Japanese Inn Has Been Open For 1,300 Years

It's one of the oldest family businesses in the world.

Video

What Happens Inside a Dying Mind?

Science cannot fully explain near-death experiences.

More in Health

Just In